Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
2019 pubmed 69 citations

Role of Two-Component System Response Regulator <i>bceR</i> in the Antimicrobial Resistance, Virulence, Biofilm Formation, and Stress Response of Group B Streptococcus.

Yang. Ying Y; Luo. Mingjing M; Zhou. Haokui H; Li. Carmen C; Luk. Alison A; Zhao. GuoPing G; Fung. Kitty K; Ip. Margaret M

Key Findings

  • bceR regulator boosts resistance to the antibiotic bacitracin and the human antimicrobial peptide LL‑37.
  • Deleting bceR sharply lowers bacterial virulence, oxidative‑stress tolerance, and biofilm formation in mice.
  • Loss of bceR also reduces expression of stress‑response proteins AhpC and Adh, and alters dltA‑mediated cell‑wall modifications.

Practical Outcomes

  • The findings are important for understanding how dangerous bacteria evade the immune system, but they don't provide any direct, actionable advice for personal health, supplementation, or longevity protocols. For biohackers, the study has little relevance to everyday self‑optimization practices.

Summary

Scientists discovered that a gene called bceR in Group B Strep bacteria helps the bug survive antibiotics and the human immune peptide LL‑37, makes it more deadly, and lets it form protective biofilms. Removing this gene makes the bacteria far weaker and easier to kill.

Abstract

Group B Streptococcus (GBS; <i>Streptococcus agalactiae</i>) is a leading cause of sepsis in neonates and pregnant mothers worldwide. Whereas the hyper-virulent serogroup III clonal cluster 17 has been associated with neonatal disease and meningitis, serogroup III ST283 was recently implicated in invasive disease among non-pregnant adults in Asia. Here, through comparative genome analyses of invasive and non-invasive ST283 strains, we identified a truncated DNA-binding regulator of a two-component system in a non-invasive strain that was homologous to <i>Bacillus subtilis bceR</i>, encoding the <i>bceRSAB</i> response regulator, which was conserved among GBS strains. Using isogenic knockout and complementation mutants of the ST283 strain, we demonstrated that resistance to bacitracin and the human antimicrobial peptide cathelicidin LL-37 was reduced in the &#x394;<i>bceR</i> strain with MICs changing from 64 and 256 &#x3bc;g/ml to 0.25 and 64 &#x3bc;g/ml, respectively. Further, the ATP-binding cassette transporter was upregulated by sub-inhibitory concentrations of bacitracin in the wild-type strain. Upregulation of <i>dltA</i> in the wild-type strain was also observed and thought to explain the increased resistance to antimicrobial peptides. DltA, an enzyme involved in D-alanylation during the synthesis of wall teichoic acids, which mediates reduced antimicrobial susceptibility, was previously shown to be regulated by the <i>bceR</i>-type regulator in <i>Staphylococcus aureus.</i> In a murine infection model, we found that the &#x394;<i>bceR</i> mutation significantly reduced the mortality rate compared to that with the wild-type strain (<i>p</i> &lt; 0.01). Moreover, this mutant was more susceptible to oxidative stress compared to the wild-type strain (<i>p</i> &lt; 0.001) and was associated with reduced biofilm formation (<i>p</i> &lt; 0.0001). Based on 2-DGE and mass spectrometry, we showed that downregulation of alkyl hydroperoxide reductase (AhpC), a Gls24 family stress protein, and alcohol dehydrogenase (Adh) in the &#x394;<i>bceR</i> strain might explain the attenuated virulence and compromised stress response. Together, we showed for the first time that the <i>bceR</i> regulator in GBS plays an important role in bacitracin and antimicrobial peptide resistance, virulence, survival under oxidative stress, and biofilm formation.

Study Information

Provider

pubmed

Year

2019

Date

2019-01-23T00:00:00.000Z

DOI

10.3389/fmicb.2019.00010

Citations

69

References

73